Categories: World

BRIEF-Lilly's Jaypirca (Pirtobrutinib) Significantly Reduced The Risk Of Disease Progression Or Death By 45% When Added To A Venetoclax Time-Limited Regimen In People With Previously Treated Cll/Sll

June 14 (Reuters) – Eli Lilly and Co: * LILLY'S JAYPIRCA (PIRTOBRUTINIB) SIGNIFICANTLY REDUCED THE RISK OF DISEASE PROGRESSION OR DEATH BY 45% WHEN ADDED TO A VENETOCLAX…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: June 14, 2026 12:52:12 IST

June 14 (Reuters) – Eli Lilly and Co: * LILLY'S JAYPIRCA (PIRTOBRUTINIB) SIGNIFICANTLY REDUCED THE RISK OF DISEASE PROGRESSION OR DEATH BY 45% WHEN ADDED TO A VENETOCLAX TIME-LIMITED REGIMEN IN PEOPLE

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: June 14, 2026 12:52:12 IST

Recent Posts

SANS Institute Signs MoU with UPSIFS to Develop Cybersecurity Skills in the Presence of the Hon’ble Chief Minister of Uttar Pradesh, Shri Yogi Adityanath Ji

Three-year collaboration will strengthen cybersecurity education, workforce readiness and knowledge sharing across academia and government…

October 30, 2026

Flick sends condolences to those affected by Spain's train crash

VIDEO SHOWS: FC BARCELONA PLAYERS DURING TRAINING SESSION / HEAD COACH HANSI FLICK ADDRESSING MEMBERS…

October 30, 2026

UPDATE 1-UAE says oil leak from tanker has been stopped, pollution eases

(Adds details throughout) CAIRO, Oct 30 (Reuters) - The United Arab Emirates said on Friday…

October 30, 2026